In the 12 months to Nov 19, 2026, on the open market: bought $9.9M of ACOG, SLGL, GRCE; sold $5.8M of ETON. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $9.9MInsider sales below: $5.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
GRCEBought: Grace Therapeutics, Inc. Nov 18, 20262,974 sharesfiled Nov 18, 20263,102,904 shares held indirectly after, as filedfiling$5K
GRCEBought: Grace Therapeutics, Inc. Nov 17, 202629,207 sharesfiled Nov 18, 20263,099,930 shares held indirectly after, as filedfiling$50K
GRCEBought: Grace Therapeutics, Inc. Nov 16, 202615,879 sharesfiled Nov 18, 20263,070,723 shares held indirectly after, as filedfiling$28K
GRCEBought: Grace Therapeutics, Inc. Nov 5, 20263,087 sharesfiled Nov 5, 20263,054,853 shares held indirectly after, as filedfiling$5K
GRCEBought: Grace Therapeutics, Inc. Nov 4, 20265,027 sharesfiled Nov 5, 20263,051,766 shares held indirectly after, as filedfiling$9K
GRCEBought: Grace Therapeutics, Inc. Nov 3, 202610,328 sharesfiled Nov 5, 20263,046,739 shares held indirectly after, as filedfiling$18K
GRCEBought: Grace Therapeutics, Inc. Oct 26, 202666,411 sharesfiled Oct 26, 20263,036,411 shares held indirectly after, as filedfiling$117K
ACOGBought: Alpha Cognition Inc. Oct 23, 202614,973 sharesfiled Oct 26, 20263,291,984 shares held indirectly after, as filedfiling$123K
ACOGBought: Alpha Cognition Inc. Oct 22, 202617,117 sharesfiled Oct 26, 20263,277,011 shares held indirectly after, as filedfiling$143K
GRCEBought: Grace Therapeutics, Inc. Oct 22, 202621,390 sharesfiled Oct 26, 20262,970,000 shares held indirectly after, as filedfiling$41K
GRCEBought: Grace Therapeutics, Inc. Oct 19, 20264,256 sharesfiled Oct 21, 20262,948,610 shares held indirectly after, as filedfiling$8K
ACOGBought: Alpha Cognition Inc. Oct 16, 202614,283 sharesfiled Oct 19, 20263,259,894 shares held indirectly after, as filedfiling$118K
GRCEBought: Grace Therapeutics, Inc. Oct 16, 202636,347 sharesfiled Oct 16, 20262,944,354 shares held indirectly after, as filedfiling$69K
ACOGBought: Alpha Cognition Inc. Oct 15, 202622,657 sharesfiled Oct 19, 20263,245,611 shares held indirectly after, as filedfiling$191K
GRCEBought: Grace Therapeutics, Inc. Oct 15, 202623,485 sharesfiled Oct 16, 20262,908,007 shares held indirectly after, as filedfiling$46K
GRCEBought: Grace Therapeutics, Inc. Oct 14, 202611,233 sharesfiled Oct 16, 20262,884,522 shares held indirectly after, as filedfiling$22K
GRCEBought: Grace Therapeutics, Inc. Oct 12, 20267,215 sharesfiled Oct 13, 20262,873,289 shares held indirectly after, as filedfiling$15K
GRCEBought: Grace Therapeutics, Inc. Oct 9, 20265,340 sharesfiled Oct 13, 20262,866,074 shares held indirectly after, as filedfiling$11K
GRCEBought: Grace Therapeutics, Inc. Oct 8, 20262,077 sharesfiled Oct 13, 20262,860,734 shares held indirectly after, as filedfiling$4K
GRCEBought: Grace Therapeutics, Inc. Oct 5, 20261,694 sharesfiled Oct 5, 20262,858,657 shares held indirectly after, as filedfiling$3K
GRCEBought: Grace Therapeutics, Inc. Oct 2, 202620,000 sharesfiled Oct 5, 20262,856,963 shares held indirectly after, as filedfiling$41K
ACOGBought: Alpha Cognition Inc. Oct 1, 202619,050 sharesfiled Oct 2, 20263,222,954 shares held indirectly after, as filedfiling$166K
GRCEBought: Grace Therapeutics, Inc. Oct 1, 202638,796 sharesfiled Oct 5, 20262,836,963 shares held indirectly after, as filedfiling$79K
GRCEBought: Grace Therapeutics, Inc. Sep 29, 20267,849 sharesfiled Oct 1, 20262,798,167 shares held indirectly after, as filedfiling$16K
ACOGBought: Alpha Cognition Inc. Sep 25, 202613,426 sharesfiled Sep 28, 20263,203,904 shares held indirectly after, as filedfiling$114K
ACOGBought: Alpha Cognition Inc. Sep 24, 202618,337 sharesfiled Sep 28, 20263,190,478 shares held indirectly after, as filedfiling$157K
GRCEBought: Grace Therapeutics, Inc. Sep 23, 20265,318 sharesfiled Oct 1, 20262,790,318 shares held indirectly after, as filedfiling$11K
GRCEBought: Grace Therapeutics, Inc. Sep 21, 20269,771 sharesfiled Oct 1, 20262,785,000 shares held indirectly after, as filedfiling$21K
SLGLBought: Sol-Gel Technologies Ltd. Jul 2, 20261,400 sharesfiled Jul 2, 2026491,712 shares held indirectly after, as filedfiling$101K
SLGLBought: Sol-Gel Technologies Ltd. Jul 1, 2026312 sharesfiled Jul 2, 2026490,312 shares held indirectly after, as filedfiling$22K
ACOGBought: Alpha Cognition Inc. Jun 26, 2026152,336 sharesfiled Jun 29, 20262,805,107 shares held indirectly after, as filedfiling$975K
ACOGBought: Alpha Cognition Inc. Jun 25, 2026197 sharesfiled Jun 29, 20262,652,771 shares held indirectly after, as filedfiling$1K
ACOGBought: Alpha Cognition Inc. Jun 15, 20264,550 sharesfiled Jun 15, 20262,652,574 shares held indirectly after, as filedfiling$27K
ACOGBought: Alpha Cognition Inc. Jun 12, 2026273 sharesfiled Jun 15, 20262,648,024 shares held indirectly after, as filedfiling$2K
ACOGBought: Alpha Cognition Inc. Jun 11, 20262,862 sharesfiled Jun 15, 20262,647,751 shares held indirectly after, as filedfiling$17K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
Stakes filed (13D/13G)
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Filings made under this filer's SEC CIK in the same 12 months, newest first; the figure is the percentage the filing states. Every recent 13D and 13G
RZLTOpaleye Management Inc. filed Nov 13, 2026Schedule 13G/Apassive3,952,045 sharesissuer: Rezolute, Inc.filing4.09%
SLGLOpaleye Management Inc. filed Nov 6, 2026Schedule 13G/Apassiveissuer: Sol-Gel Technologies Ltdfiling16.49%
ETONOpaleye Management Inc. filed Nov 6, 2026Schedule 13G/Apassiveissuer: ETON PHARMACEUTICALS, INC.filing8.54%
GOSSOpaleye Management Inc. filed Nov 6, 2026Schedule 13G/Apassive426,989 sharesissuer: Gossamer Bio, Inc.filing6.98%
HROWOpaleye Management Inc. filed Nov 6, 2026Schedule 13G/Apassive2,105,000 sharesissuer: Harrow, Inc.filing5.62%
QTTBOpaleye Management Inc. filed Nov 6, 2026Schedule 13G/Apassive1,120,000 sharesissuer: Q32 Bio Inc.filing3.76%
CDXSOpaleye Management Inc. filed Nov 6, 2026Schedule 13G/Apassive2,590,000 sharesissuer: Codexis, Inc.filing2.37%
KTTAOpaleye Management Inc. filed Nov 6, 2026Schedule 13G/Apassive0 sharesissuer: Pasithea Therapeutics Corp.filing0%
GRCEOpaleye Management Inc. filed Aug 7, 2026Schedule 13Gpassive2,748,392 sharesissuer: Grace Therapeutics, Inc.filing13.07%